PainChek Ltd ( (AU:PCK) ) has provided an announcement.
PainChek Ltd has announced the application for quotation of 27,549,501 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and is expected to enhance the company’s capital structure, potentially impacting its market positioning and providing opportunities for stakeholders.
More about PainChek Ltd
PainChek Ltd operates in the healthcare industry, focusing on developing and providing pain assessment technologies. The company’s primary product is a digital pain assessment tool designed to improve pain management practices across various healthcare settings.
YTD Price Performance: 13.33%
Average Trading Volume: 1,024,895
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$58.06M
Find detailed analytics on PCK stock on TipRanks’ Stock Analysis page.